D.E. Shaw & Co’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-28,500
Closed -$295K 4014
2020
Q1
$295K Buy
28,500
+19,700
+224% +$551K ﹤0.01% 3480
2019
Q4
$331K Sell
8,800
-64,900
-88% -$2.92M ﹤0.01% 3591
2019
Q3
$3.44M Sell
73,700
-18,300
-20% -$851K ﹤0.01% 1932
2019
Q2
$4.81M Buy
92,000
+45,600
+98% +$2.67M 0.01% 1617
2019
Q1
$3.2M Buy
46,400
+26,800
+137% +$1.8M ﹤0.01% 1836
2018
Q4
$1.17M Buy
+19,600
New +$1.69M ﹤0.01% 2552
2015
Q4
Sell
-43,500
Closed -$4.34M 3805
2015
Q3
$4.34M Buy
43,500
+23,500
+118% +$2.56M 0.01% 1506
2015
Q2
$2.28M Sell
20,000
-20,300
-50% -$2.46M ﹤0.01% 2088
2015
Q1
$4.21M Buy
40,300
+10,000
+33% +$1.07M 0.01% 1489
2014
Q4
$3.65M Sell
30,300
-4,200
-12% -$552K ﹤0.01% 1797
2014
Q3
$5.05M Buy
+34,500
New +$5.33M 0.01% 1562
2014
Q2
Sell
-34,000
Closed -$6.75M 4224
2014
Q1
$6.75M Sell
34,000
-27,900
-45% -$5.27M 0.01% 1335
2013
Q4
$11.8M Buy
61,900
+10,100
+19% +$1.88M 0.02% 1015
2013
Q3
$8.77M Sell
51,800
-47,800
-48% -$7.42M 0.01% 1125
2013
Q2
$15.1M Buy
+99,600
New +$14.1M 0.03% 642

Other funds holding CLB

D.E. Shaw & Co's CLB Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Core Laboratories (CLB) stake by 29% in Q1 2026, selling an estimated $885K and leaving 118,426 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

D.E. Shaw & Co first reported a position in CLB in Q2 2013 and has held it in 43 quarters since. The position peaked at $12.8M in Q2 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • D.E. Shaw & Co held 118,426 shares of Core Laboratories worth $1.99M as of Q1 2026.
  • D.E. Shaw & Co sold 49,458 Core Laboratories shares in Q1 2026, an estimated $885K.
  • Core Laboratories made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2920 holding.
  • D.E. Shaw & Co first reported a position in Core Laboratories in Q2 2013 and has held it in 43 quarters since.
  • D.E. Shaw & Co's Core Laboratories position peaked at $12.8M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.